Future PSVR Systems Could Track Early Signs of Alzheimer's
A patent filed by Sony Group Corporation points to the company utilizing its future PS VR devices as diagnostic tools to identify early signs of disorders such as Alzheimer's and other forms of dementia. The power of Sony's PS VR2 is setting new standards for virtual reality hardware, and its next accolade may be as an instrument for medical diagnoses.
Launched on February 22, Sony's PS VR2 is being lauded as a fantastic piece of hardware that pushes the boundaries of virtual reality technology. Its ease of setup, improved light shield along with other impressive technical specs, and its immersive haptic feedback and adaptive triggers for its Sense controllers are all among the elements praised in its design. Sony also supported the launch of PSVR 2 with more than 30 compatible games, including the highly touted Horizon Call of the Mountain, along with another 100 games on the way. Its biggest issue, however, is a rather consumer-unfriendly cost for entry, with the headset starting at $549.99 and requiring the purchase of a Playstation 5 to boot.
RELATED: Episodic Murder Mystery Dyschronia: Chronos Alternate Coming to PS VR2
On March 16, 2023, a patent was published from the Sakai International Patent Office which shows Sony Group Corporation's intent to utilize its PS VR technology as an instrument in diagnostic medicine. Sony seeks to create a «method and computer program product for measuring a level of cognitive decline in a user.» According to the patent, the method functions by generating a spatial audio cue from a specific source within a three-dimensionally generated environment, where the user must indicate that source via ocular focus. A second audio cue is then played for the user to determine its originating
Read more on gamerant.com
